Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$0.63 - $1.1 $33,130 - $57,846
-52,588 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$0.68 - $2.14 $27,118 - $85,343
39,880 Added 313.82%
52,588 $38,000
Q4 2019

Feb 14, 2020

BUY
$0.65 - $1.68 $375 - $969
577 Added 4.76%
12,708 $21,000
Q3 2019

Nov 14, 2019

BUY
$1.06 - $1.87 $12,858 - $22,684
12,131 New
12,131 $13,000
Q2 2018

Aug 14, 2018

SELL
$1.61 - $2.9 $24,605 - $44,320
-15,283 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.6 - $4.95 $39,735 - $75,650
15,283 New
15,283 $40,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $322M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.